Muscle Relaxants, Central
"Muscle Relaxants, Central" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358)
| Descriptor ID |
D009125
|
| MeSH Number(s) |
D27.505.696.510 D27.505.696.663.700.600 D27.505.954.427.525
|
| Concept/Terms |
Muscle Relaxants, Central- Muscle Relaxants, Central
- Central Muscle Relaxants
- Relaxants, Central Muscle
- Centrally Acting Muscle Relaxants
|
Below are MeSH descriptors whose meaning is more general than "Muscle Relaxants, Central".
Below are MeSH descriptors whose meaning is more specific than "Muscle Relaxants, Central".
This graph shows the total number of publications written about "Muscle Relaxants, Central" by people in this website by year, and whether "Muscle Relaxants, Central" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 0 | 1 |
| 2001 | 1 | 1 | 2 |
| 2003 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 2 | 3 |
| 2019 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Muscle Relaxants, Central" by people in Profiles.
-
Characterization of standard work tools for intrathecal baclofen therapy. Childs Nerv Syst. 2021 10; 37(10):3073-3081.
-
Succinylcholine Use and Dantrolene Availability for Malignant Hyperthermia Treatment: Database Analyses and Systematic Review. Anesthesiology. 2019 01; 130(1):41-54.
-
Neurosurgical Management of Spastic Conditions of the Upper Extremity. Hand Clin. 2018 Nov; 34(4):547-554.
-
Placement of baclofen pump catheter through a C1-2 puncture: technical note. J Neurosurg Pediatr. 2018 04; 21(4):389-394.
-
A standardized protocol to reduce pediatric baclofen pump infections: a quality improvement initiative. J Neurosurg Pediatr. 2018 04; 21(4):395-400.
-
Quinine-Induced Thrombotic Microangiopathy: A Report of 19 Patients. Am J Kidney Dis. 2017 Nov; 70(5):686-695.
-
The effect of baclofen on nocturnal gastroesophageal reflux and measures of sleep quality: a randomized, cross-over trial. Neurogastroenterol Motil. 2012 Jun; 24(6):553-9, e253.
-
Comprehension of affective prosody in multiple sclerosis. Mult Scler. 2003 Mar; 9(2):148-53.
-
Quinine-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: frequency, clinical features, and long-term outcomes. Ann Intern Med. 2001 Dec 18; 135(12):1047-51.
-
Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Curr Opin Hematol. 2001 Sep; 8(5):286-93.